MAPK1 and Alzheimer disease: Also, we observed a decrease in the amyloidogenic processing marker C99 in the AD neuronal cultures with SCH772984 treatment (Supplementary Fig. 15c–e), indicating that AD oligodendrocytes predominantly contribute to the pathophysiology of AD via ERK signaling.